Inactief instrument

Koers IMV Inc. Toronto S.E.

Aandelen

Duur

Periode

Stijl

Transcript : IMV Inc., Q4 2022 Earnings Call, Mar 16, 2023	16-03-23
Transcript : IMV Inc., Q3 2022 Earnings Call, Nov 11, 2022	11-11-22
Transcript : IMV Inc., Q2 2022 Earnings Call, Aug 11, 2022	11-08-22
Transcript : IMV Inc. - Shareholder/Analyst Call	29-06-22

IMV Accepts an Offer from its Secured Lenders for the Sale of its Intellectual Property Assets	04-09-23
IMV Inc. : to Present at Two Upcoming Investor Conferences	13-06-19
Imv : De nouveaux résultats sur la combinaison de DPX-Survivac d’IMV et de Keytruda® de Merck continue de montrer des bénéfices pour le traitement du lymphome diffus à grandes cellules B (LDGCB)	12-06-19
Imv : New Phase 2 Clinical Trial Results Continue to Demonstrate Potential Clinical Benefit of IMV’s DPX-Survivac in Combination with Merck’s Keytruda in Patients with DLBCL	12-06-19

Managers	Titel	Leeftijd	Van
Andrew Hall CEO	Chief Executive Officer	-	10-11-20
Brittany Davison DFI	Director of Finance/CFO	-	-
Jennifer Schmitke COO	Chief Operating Officer	-	-

Besturend	Titel	Leeftijd	Van
Michael P. Bailey CHM	Chairman	58	01-07-20
Kyle Kuvalanka BRD	Director/Board Member	56	01-04-21
Markus Warmuth BRD	Director/Board Member	53	06-11-18

IMV Inc. is een in Canada gevestigd bedrijf. Het bedrijf heeft geen bedrijfsactiviteiten.

Sector

	Vaira. 1 jan.	Kapi.
IQVIA HOLDINGS INC.	+1,51%	42,75 mld.
LONZA GROUP AG	+49,22%	41,61 mld.
MODERNA, INC.	+8,57%	41,34 mld.
CELLTRION, INC.	-12,36%	26,59 mld.
ICON PUBLIC LIMITED COMPANY	+8,92%	25,49 mld.
ALNYLAM PHARMACEUTICALS, INC.	-25,13%	18,12 mld.
MEDPACE HOLDINGS, INC.	+29,17%	12,24 mld.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-3,12%	11,76 mld.
UNITED THERAPEUTICS CORPORATION	+6,35%	11 mld.